<VariationArchive VariationID="500061" VariationName="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs)" VariationType="Deletion" Accession="VCV000500061" Version="25" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-06-23" DateCreated="2018-04-02" MostRecentSubmission="2024-04-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="491485" VariationID="500061">
      <GeneList>
        <Gene Symbol="MYO15A" FullName="myosin XVA" GeneID="51168" HGNC_ID="HGNC:7594" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="18108756" stop="18179800" display_start="18108756" display_stop="18179800" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="18012019" stop="18083115" display_start="18012019" display_stop="18083115" Strand="+" />
          </Location>
          <OMIM>602666</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_016239.4(MYO15A):c.1137del (p.Tyr380fs)</Name>
      <CanonicalSPDI>NC_000017.11:18119933:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="18119934" stop="18119934" display_start="18119934" display_stop="18119934" variantLength="1" positionVCF="18119933" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="18023248" stop="18023248" display_start="18023248" display_stop="18023248" variantLength="1" positionVCF="18023247" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_016239.4(MYO15A):c.1137del</Name>
        <Name>p.Tyr380fs</Name>
      </OtherNameList>
      <ProteinChange>Y380fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.18023251del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.18023251del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.18119937del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.18119937del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011634.2" sequenceAccession="NG_011634" sequenceVersion="2" change="g.16232del">
            <Expression>NG_011634.2:g.16232del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016239.4" sequenceAccession="NM_016239" sequenceVersion="4" change="c.1137del" MANESelect="true">
            <Expression>NM_016239.4:c.1137del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057323.3" sequenceAccession="NP_057323" sequenceVersion="3" change="p.Tyr380fs">
            <Expression>NP_057323.3:p.Tyr380fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016239.3" sequenceAccession="NM_016239" sequenceVersion="3" change="c.1137del">
            <Expression>NM_016239.3:c.1137del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA8423030" DB="ClinGen" />
        <XRef Type="rs" ID="769260536" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs) AND not provided" Accession="RCV000597925" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs) AND Autosomal recessive nonsyndromic hearing loss 3" Accession="RCV000779205" Version="10">
        <ClassifiedConditionList TraitSetID="1920">
          <ClassifiedCondition DB="MedGen" ID="C1838263">Autosomal recessive nonsyndromic hearing loss 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2017-11-24" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs) AND Rare genetic deafness" Accession="RCV001195292" Version="5">
        <ClassifiedConditionList TraitSetID="40993">
          <ClassifiedCondition DB="MedGen" ID="C5680250">Rare genetic deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs) AND Hearing impairment" Accession="RCV001375258" Version="3">
        <ClassifiedConditionList TraitSetID="8456">
          <ClassifiedCondition DB="MedGen" ID="C1384666">Hearing impairment</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_016239.4(MYO15A):c.1137del (p.Tyr380fs) AND Nonsyndromic genetic hearing loss" Accession="RCV002232560" Version="2">
        <ClassifiedConditionList TraitSetID="9568">
          <ClassifiedCondition DB="MedGen" ID="C5680182">Nonsyndromic genetic hearing loss</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-03-20" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-20" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2018-04-02" MostRecentSubmission="2024-04-06">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17546645</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23208854</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24123792</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24875298</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28000701</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31980526</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MYO15A</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/507ceb3d-5622-40fb-904a-ccf18ccf0973</URL>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40993" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="38576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rare genetic deafness</ElementValue>
                <XRef ID="96210" DB="Orphanet" />
              </Name>
              <XRef ID="96210" DB="Orphanet" />
              <XRef ID="C5680250" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1920" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1711" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 3</ElementValue>
                <XRef ID="Deafness%2C+autosomal+recessive+3/8169" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 3</ElementValue>
                <XRef Type="MIM" ID="600316" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 3</ElementValue>
                <XRef ID="MONDO:0010860" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNB3</ElementValue>
                <XRef Type="MIM" ID="600316" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NSRD3</ElementValue>
                <XRef Type="MIM" ID="600316" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22583" />
                <XRef ID="22583" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C1838263" DB="MedGen" />
              <XRef ID="MONDO:0010860" DB="MONDO" />
              <XRef Type="MIM" ID="600316" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9568" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9544" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Non-syndromic genetic deafness</ElementValue>
                <XRef ID="87884" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic hearing loss and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic genetic deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nonsyndromic genetic hearing loss</ElementValue>
                <XRef ID="MONDO:0019497" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6410" />
                <XRef ID="6410" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19091" />
                <XRef ID="19091" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng98</URL>
                <CitationText>UK NICE Guideline (NG98), Hearing loss in adults: assessment and management, 2023</CitationText>
              </Citation>
              <XRef ID="87884" DB="Orphanet" />
              <XRef ID="C5680182" DB="MedGen" />
              <XRef ID="MONDO:0019497" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8456" Type="Finding" ContributesToAggregateClassification="false">
            <Trait ID="17089" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Hearing impairment</ElementValue>
                <XRef ID="HP:0000365" DB="Human Phenotype Ontology" />
              </Name>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24651602</ID>
              </Citation>
              <XRef ID="C1384666" DB="MedGen" />
              <XRef ID="MONDO:0005365" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000365" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000404" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001728" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001729" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001754" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008560" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0008563" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1378239" SubmissionDate="2018-09-19" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="59150_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000705841" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-02-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23208854</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24875298</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="-" referenceAllele="C" start="18023251" stop="18023251" variantLength="1" />
            <GeneLocation>NM_016239.3:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD136601" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MYO15A</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790821" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1364033" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915746" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24875298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23208854</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24123792</ID>
          </Citation>
          <Comment>The MYO15A c.1137delC (p.Tyr380MetfsTer64) variant is a frameshift variant that is predicted to result in premature termination of the protein. This variant has been reported in a compound heterozygous state along with a second null variant in three individuals with hearing loss (Schrauwen et al. 2013; Neveling et al. 2013; Vona et al. 2014). The individual identified in the Vona et al. (2014) study also carried the c.7C&gt;G (p.Gln3Glu) missense variant in the MYH9 gene. The p.Tyr380MetfsTer64 variant was absent from nine normal hearing controls, but is reported at a frequency of 0.00038 in the European American population of the Exome Sequencing Project. Based on the evidence and due to the potential impact of frameshift variants, the p.Tyr380MetfsTer64 is classified as likely pathogenic for autosomal recessive nonsyndromic hearing loss. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="T" referenceAllele="TC" start="18023247" stop="18023248" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016239.3:c.1137delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600316" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2693500" SubmissionDate="2020-05-14" DateLastUpdated="2020-07-04" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="100389155|Orphanet:ORPHA96210" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001365603" DateUpdated="2020-07-04" DateCreated="2020-07-04" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28000701</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23208854</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24123792</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24875298</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31980526</ID>
          </Citation>
          <Comment>The p.Tyr380MetfsX64 variant in MYO15A has been previously reported in at least 3 individuals with hearing loss who were compound heterozygous for a second truncating MYO15A variant (Neveling 2013, Schrauwen 2013, Vona 2014, Zazo Seco 2017, Hou 2020). This variant has been identified in 0.02% (26/128476) of European chromosomes by gnomad chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 380 and leads to a premature termination codon 64 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the MYO15A gene is an established disease mechanism in autosomal recessive hearing loss. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive hearing loss. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3_Strong.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.18023251delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA96210" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7448406</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2454599" SubmissionDate="2020-08-30" DateLastUpdated="2020-09-18" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="NM_016239.3:c.1137delC|OMIM:600316" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001244797" DateUpdated="2020-09-18" DateCreated="2020-05-04" Type="SCV" Version="2" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous frameshift deletion variant, NM_016239.3(MYO15A):c.1137delC, has been identified in exon 2 of 66 of the MYO15A gene. This deletion is predicted to create a frameshift starting at amino acid position 380, introducing a stop codon 64 residues downstream, NP_057323.3(MYO15A):p.(Tyr380Metfs*64). This variant is predicted to result in loss of protein function either through truncation (loss of majority of the protein, including all functional domains) or nonsense-mediated decay. The variant is present in the gnomAD database at a frequency of 0.01% (28 heterozygotes) andhas been previously described as a compound heterozygote with a second truncating variant in two patients with hearing loss (Schrauwen, I., et al. (2013), Vona, B. et al. (2014)). Based on the information available at the time of curation, this variant has been classified as PATHOGENIC.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">Whole Exome Sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016239.3:c.1137delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600316" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8068332</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3095396" SubmissionDate="2021-08-17" DateLastUpdated="2021-04-29" DateCreated="2021-04-29">
        <ClinVarSubmissionID localKey="NM_016239.3:c.1137del|HPO:HP:0000365" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001571736" DateUpdated="2021-04-29" DateCreated="2021-04-29" Type="SCV" Version="2" SubmitterName="Department of Otolaryngology – Head &amp; Neck Surgery, Cochlear Implant Center" OrgID="508028" OrganizationCategory="clinic" OrgAbbreviation="HNO" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23208854</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28000701</ID>
          </Citation>
          <Comment>PVS1_Very strong, PS1_Strong, PM2_Supporting, PP1_Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen HL ACMG Specifications v1</Attribute>
          <Citation>
            <ID Source="PubMed">30311386</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_016239.3:c.1137del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0000365" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10202264</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6132034" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4937410|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003441730" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17546645</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23208854</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24123792</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Tyr380Metfs*64) in the MYO15A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). This variant is present in population databases (rs769260536, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with MYO15A-related conditions (PMID: 23208854, 24123792). This variant is also known as c.1134delC. ClinVar contains an entry for this variant (Variation ID: 500061). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.18023248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="4908719" SubmissionDate="2024-03-29" DateLastUpdated="2024-04-06" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="507ceb3d-5622-40fb-904a-ccf18ccf0973" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002512114" DateUpdated="2024-04-06" DateCreated="2022-05-16" Type="SCV" Version="2" SubmitterName="ClinGen Hearing Loss Variant Curation Expert Panel" OrgID="506744" OrganizationCategory="consortium" OrgAbbreviation="HL-EP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-20">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/507ceb3d-5622-40fb-904a-ccf18ccf0973</URL>
          </Citation>
          <Comment>The c.1137del (p.Tyr380fsTer64) variant in MYO15A is frameshift variant in biologically relevant exon 2/66 that is predicted to lead to a truncated or absent protein in a gene in which loss-of-function is an established disease mechanism (PVS1). The highest population minor allele frequency in gnomAD v4.0.0 is 210/1179974 alleles (0.0001780 or 0.0178 %) in the European (non-Finnish) population (PM2_supporting, BS1, and BA1 not met). This variant has been detected in 3 individuals with nonsyndromic hearing loss. For each of those individuals, they were compound heterozygous for the variant and a pathogenic or likely pathogenic variant, but phase was not confirmed (p.Lys1003fsTer55, p.Glu209Ter, p.Arg3134Ter; PMIDs: 23208854, 28000701, 31980526; 1.5 pts. PM3). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive nonsyndromic hearing loss based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: (PVS1, PM3; Version 1; 3/20/2024).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">clingen hl acmg specifications otof myo15a v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/cpszveq5/clingen_hl_acmg_specifications_otof_myo15a_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYO15A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_016239.4(MYO15A):c.1137del</Name>
            <Name>p.Tyr380fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.18119937del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0019497" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11471019</SubmissionName>
          <SubmissionName>SUB14346304</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1790821" TraitType="Disease" MappingType="XRef" MappingValue="600316" MappingRef="OMIM">
        <MedGen CUI="C1838263" Name="Autosomal recessive nonsyndromic hearing loss 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6132034" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1378239" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2454599" TraitType="Disease" MappingType="XRef" MappingValue="600316" MappingRef="OMIM">
        <MedGen CUI="C1838263" Name="Autosomal recessive nonsyndromic hearing loss 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3095396" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000365" MappingRef="HP">
        <MedGen CUI="C1384666" Name="Hearing impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4908719" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0019497" MappingRef="MONDO">
        <MedGen CUI="C5680182" Name="Nonsyndromic genetic hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2693500" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA96210" MappingRef="Orphanet">
        <MedGen CUI="C5680250" Name="Rare genetic deafness" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001520192</Accession>
        <Description>not specified</Description>
      </SCV>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002017688</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

